Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases.
D002851:Chromatography, High Pressure Liquid; D004317:Doxorubicin / Q000097:blood*; D015251:Epirubicin; D006207:Half-Life; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D007700:Kinetics; D008113:Liver Neoplasms / Q000556:secondary*; D009369:Neoplasms / Q000097:blood*; D013997:Time Factors
D015251:Epirubicin; D004317:Doxorubicin